Wockhardt Daman plant GMP compliant: UK MHRA
New Delhi: Drug firm Wockhardt said the UK health regulator has confirmed that its Daman-based manufacturing facility complies with good manufacturing practices (GMP).
"UK MHRA (The Medicines and Healthcare products Regulatory Agency) has since confirmed that our manufacturing unit at Kadaiya Damancomplies with the principles and guidelines of good manufacturing practices," Wockhardt said in a regulatory filing.
In view of this, the approval status of the said unit continues, it added.
"UK MHRA (The Medicines and Healthcare products Regulatory Agency) has since confirmed that our manufacturing unit at Kadaiya Damancomplies with the principles and guidelines of good manufacturing practices," Wockhardt said in a regulatory filing.
In view of this, the approval status of the said unit continues, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd